In the case of Brugada Syndrome (BrS), a serious genetic condition that causes a disruption of the heart's normal rhythm and predisposes a patient to sudden arrhythmic death, many clinical laboratories have based their test design and diagnostic reporting on the literature implicating 21 genes with the condition
All news from Anaesthesiology
In the study comparing brain images of school-aged youths born just prior to the fortification mandate to those of young people born afterward, a Massachusetts General Hospital (MGH)-based research team found that increased in utero folic acid exposure was associated with changes in later brain development
Scientists have developed an immunotherapy that uses immune cells cultured from stem cells instead of cells that are taken from patients to seek and destroy cancer cells.
Seaweeds contain many biological components including proteins, peptides, amino acids, fibers, lipids, pigments, phenols, and polysaccharides, making them an attractive source for potential agricultural and health benefits.
Thirteen years after the first successful face transplant, US trauma surgeons should be aware of the current role of facial transplantation for patients with severe facial disfigurement.
The U.S. Food and Drug Administration has approved the first biosimilar to pegfilgrastim (Neulasta, Amgen), a granulocyte colony-stimulating factor used to reduce infection risk in patients with cancer.
Targeted therapy with a single agent has improved survival in comparison with standard-of-care chemotherapy in a subgroup of patients with acute myeloid leukemia (AML).
A recent study of the design of operating rooms, one of the most critical areas in a hospital reveals how research-informed design could improve the safety and performance of the hospital staff.
A new ultrasound system that uses optical, instead of electronic components, could improve performance while giving doctors significantly more flexibility in how they use ultrasound to diagnose and treat medical problems.
Rabin Medical Center (RMC) has selected RayStation for radiation therapy treatment planning at its Davidoff Cancer Center, Israel. This is the first order from a clinic in Israel, and the installation will include licenses for 3DCRT, IMRT, VMAT and adaptive therapy.
Nonalcoholic fatty liver disease, (NAFLD) which affects roughly 100 million Americans, costs the United States healthcare system $32 billion annually, according to a study by Intermountain Healthcare researchers on the economic impact of the disease.
Using sound waves, an international team of researchers has developed a gentle, contact-free method for separating circulating tumor cells from blood samples that is fast and efficient enough for clinical use.